KAY THOMPSON: Open Payments
NPI 1184694119 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 47 payments from 16 companies in 2025. Trend: 2023 $110 · 2024 $462 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $161 |
| Novo Nordisk Inc | 13 | $160 |
| Lundbeck LLC | 3 | $84 |
| ABBVIE INC. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Lilly USA, LLC | 2 | $30 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| CSL Behring | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: REXULTI, NURTEC ODT, JARDIANCE, TRELEGY ELLIPTA, PREVNAR 20, VRAYLAR, Ozempic, ELIQUIS.
Industry payments across PA — which companies pay providers there.
